29.6.2023

Four wins for Castrén & Snellman in Women in Business Law Awards EMEA 2023

Castrén & Snellman was selected as Scandinavian Firm of the Year at the Women in Business Law Awards EMEA for the third year running. In addition, our firm received the Work-Life Balance National Firm of the Year and Diverse Women Lawyers National Firm of the Year awards for the first time.

Partner Pauliina Tenhunen, who has been with Castrén & Snellman for over 30 years, received the Outstanding Achievement award. The recipients of personal awards are decided based on their professional accomplishments as well as advocacy and influence within their field.

‘These acknowledgements mean a great deal to us, as equality has been a key target for us for a long time. My younger colleagues are always amused when I tell them how I was the only woman lawyer at Castrén & Snellman in the early 90s. That seems like a very distant past now that over half of our lawyers and a third of our partners are women,’ says Tenhunen.

A Forerunner in Equality

For Castrén & Snellman, equality is not just equality between genders. As part of our equality work, we have continued our diversity training for the entire personnel, and all of our new employees take part in an induction course on diversity.

The Women in Business Law EMEA awards are granted to law firms as recognitions of their efforts in helping women to advance in the legal profession in the EMEA region. In addition, the awards highlight the most ground-breaking achievements by leading women lawyers. The WIBL Awards are organised in cooperation with IFLR, ITR, Managing IP, Benchmark Litigation and Euromoney Legal Media Group Expert Guides. To read more, visit the Women in Business Law Awards EMEA 2023 web page.

Latest references

We advised Cibus Real Estate AB (publ) on its acquisition of three newly built retail properties in Pori, Finland.  Kesko is the tenant in all three properties, and the average lease term is 8.1 years. Cibus is a real estate company listed on Nasdaq Stockholm Mid Cap. The company’s business concept is to acquire, develop and manage properties in Europe with daily goods chains as anchor tenants. The company currently owns approximately 700 properties in Europe.
Case published 12.11.2026
We advised Seaya Nova and Molten Ventures as Finnish counsel in connection with the USD 80 million Series C financing of Pliant, a Berlin-based fintech specialising in B2B payment solutions and corporate credit cards. The financing round was led by Seaya Nova and Speedinvest, with participation from Illuminate Financial, Motive Partners, Molten Ventures and Citi Ventures. Founded in Berlin in 2020, Pliant provides modular payment solutions for businesses and holds an EU e-money licence in Finland as well as a licence from the UK Financial Conduct Authority. We advised on the Finnish law aspects of the transaction alongside YPOG, which acted as lead counsel to Seaya Nova and Molten Ventures.
Case published 12.11.2026
We advised Nala Renewables on the Finnish law aspects of the development, acquisition and financing of its battery energy storage system (BESS) project in Vuolijoki, Finland. The project comprises a 125 MW / 250 MWh battery energy storage system. Our advice extended beyond financing to the transaction’s legal due diligence and the acquisition of the project company. We also advised on key project contracts and financing documentation for the project finance facilities provided by Coöperatieve Rabobank U.A. The project is part of Nala Renewables’ growing portfolio of battery storage assets in Finland and the wider Nordic region, supporting the integration of renewable energy and contributing to the flexibility and stability of the Finnish electricity grid.
Case published 3.11.2026
We advised Foundation Clinic in connection with its funding round backed by a group of prominent Finnish technology entrepreneurs and investors, including founders behind Supercell and Wolt. Foundation Clinic is a Finnish healthcare company developing a new approach to private healthcare focused on preventive, data-driven and continuous care. The company aims to combine comprehensive health data with ongoing medical care to identify and address health risks at an early stage.
Case published 29.10.2026